Contingent Liabilities and Commitments (Details) € in Thousands |
6 Months Ended |
---|---|
Jun. 30, 2024
EUR (€)
| |
Contingent Liabilities and Commitments [Line Items] | |
Commission income expense | € 25 |
Annual royalties | 10 |
Royalties amount | € 850 |
Royalty payments, percentage | 10.00% |
Phase I studies [Member] | |
Contingent Liabilities and Commitments [Line Items] | |
Royalties amount | € 50 |
Phase II studies [Member] | |
Contingent Liabilities and Commitments [Line Items] | |
Royalties amount | 100 |
Phase III studies [Member] | |
Contingent Liabilities and Commitments [Line Items] | |
Royalties amount | 200 |
Regulatory Authority [Member] | |
Contingent Liabilities and Commitments [Line Items] | |
Royalties amount | € 500 |
Minimum [Member] | |
Contingent Liabilities and Commitments [Line Items] | |
Percentage of net sales | 2.00% |
Maximum [Member] | |
Contingent Liabilities and Commitments [Line Items] | |
Percentage of net sales | (3.00%) |
X | ||||||||||
- Definition The percentage of net sales. No definition available.
|
X | ||||||||||
- Definition The royalty payment in percentage. No definition available.
|
X | ||||||||||
- Definition The amount paid to music publishers, record producers, songwriters, or other artists in advance of their earning royalties from record or music sales. Such an amount is based on contractual terms and is generally nonrefundable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of fees incurred for commissions on mutual funds and insurance products. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|